UnitedHealth Group Incorporated (UNH) Position Increased by Weiss Multi Strategy Advisers LLC

Weiss Multi Strategy Advisers LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,063 shares of the healthcare conglomerate’s stock after buying an additional 7 shares during the period. Weiss Multi Strategy Advisers LLC’s holdings in UnitedHealth Group were worth $1,814,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of UNH. Jackson Grant Investment Advisers Inc. raised its position in UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock valued at $180,000 after buying an additional 4 shares during the period. Adirondack Trust Co. raised its position in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares during the period. Paradigm Financial Advisors LLC raised its position in UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the period. Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Harwood Advisory Group LLC raised its position in UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock valued at $309,000 after buying an additional 15 shares during the period. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded up 0.33% during midday trading on Friday, reaching $193.20. 748,274 shares of the company were exchanged. The company’s 50-day moving average price is $189.18 and its 200 day moving average price is $174.51. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The stock has a market capitalization of $186.80 billion, a price-to-earnings ratio of 23.21 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.96 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/unitedhealth-group-incorporated-unh-position-increased-by-weiss-multi-strategy-advisers-llc.html.

Several brokerages have issued reports on UNH. UBS AG reaffirmed a “buy” rating and set a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $205.00 price objective (up previously from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Finally, Citigroup Inc. raised their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $200.24.

In other news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,540 shares of company stock valued at $2,873,320. Company insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit